Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Metabotropic Glutamate | 2 | 2020 | 195 | 1.080 |
Why?
|
Biophysical Phenomena | 1 | 2020 | 320 | 0.670 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2015 | 144 | 0.490 |
Why?
|
Allosteric Regulation | 1 | 2015 | 426 | 0.450 |
Why?
|
Career Choice | 1 | 2019 | 756 | 0.420 |
Why?
|
Neurology | 1 | 2019 | 780 | 0.370 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.220 |
Why?
|
Internship and Residency | 1 | 2019 | 5882 | 0.160 |
Why?
|
Training Support | 1 | 2019 | 109 | 0.160 |
Why?
|
Receptor, Serotonin, 5-HT2A | 2 | 2016 | 64 | 0.160 |
Why?
|
Status Epilepticus | 1 | 2024 | 460 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2024 | 710 | 0.150 |
Why?
|
Protein Structure, Secondary | 1 | 2020 | 1229 | 0.140 |
Why?
|
Serotonin 5-HT2 Receptor Antagonists | 1 | 2016 | 23 | 0.140 |
Why?
|
Schizophrenia | 1 | 2015 | 6937 | 0.130 |
Why?
|
Rotenone | 2 | 2013 | 45 | 0.130 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 957 | 0.130 |
Why?
|
Receptor Cross-Talk | 1 | 2015 | 116 | 0.120 |
Why?
|
Substantia Nigra | 2 | 2013 | 350 | 0.110 |
Why?
|
Ligands | 1 | 2020 | 3272 | 0.110 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2014 | 144 | 0.110 |
Why?
|
Membrane Potentials | 1 | 2016 | 1090 | 0.110 |
Why?
|
Oocytes | 2 | 2016 | 1166 | 0.100 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.100 |
Why?
|
Colchicine | 1 | 2012 | 259 | 0.090 |
Why?
|
Thyroxine | 1 | 2013 | 666 | 0.080 |
Why?
|
Neurotoxicity Syndromes | 1 | 2013 | 301 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1250 | 0.070 |
Why?
|
Catalepsy | 2 | 2013 | 31 | 0.050 |
Why?
|
Parkinson Disease | 2 | 2013 | 2877 | 0.050 |
Why?
|
Tremor | 2 | 2013 | 191 | 0.050 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2013 | 370 | 0.050 |
Why?
|
Xenopus laevis | 2 | 2016 | 963 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13642 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23447 | 0.040 |
Why?
|
Thalamus | 1 | 2024 | 1047 | 0.040 |
Why?
|
Ketanserin | 1 | 2016 | 24 | 0.030 |
Why?
|
Barium | 1 | 2016 | 62 | 0.030 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2016 | 61 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18253 | 0.030 |
Why?
|
Corpus Striatum | 2 | 2013 | 1235 | 0.030 |
Why?
|
Tritium | 1 | 2016 | 708 | 0.030 |
Why?
|
Serotonin Antagonists | 1 | 2016 | 145 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 398 | 0.030 |
Why?
|
Risperidone | 1 | 2016 | 381 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3113 | 0.030 |
Why?
|
Animals | 5 | 2016 | 168467 | 0.030 |
Why?
|
Tubulin Modulators | 1 | 2012 | 107 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 413 | 0.020 |
Why?
|
Dyskinesias | 1 | 2012 | 79 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2013 | 8181 | 0.020 |
Why?
|
Serotonin | 1 | 2016 | 1041 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2957 | 0.020 |
Why?
|
Locomotion | 1 | 2012 | 388 | 0.020 |
Why?
|
Humans | 5 | 2024 | 761572 | 0.020 |
Why?
|
Electroencephalography | 1 | 2024 | 6237 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
Rats | 2 | 2013 | 23741 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2012 | 1878 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9353 | 0.010 |
Why?
|
Microglia | 1 | 2013 | 1361 | 0.010 |
Why?
|
Calcium | 1 | 2016 | 5722 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4415 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30054 | 0.010 |
Why?
|
Female | 1 | 2014 | 392686 | 0.000 |
Why?
|
Concepts
(66)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_